TrialX readies to bring Clinical Trials Search on the iPhone

. August 2, 2009 . 0 Comments

Buoyed by the encouraging use of its PHR and Twitter-based Clinical Trial matching services, TrialX is getting ready to release its iPhone application this month. This application, designed for doctors and patients, further underscores TrialX’s commitment to promote technology-enabled consumer-driven healthcare.

Using the TrialX iPhone App, doctors can search for clinical trials that their patients may be eligible for and email the results to the patients right away. They can filter clinical trials by location, medical condition, treatment, institution conducting the trial and other parameters. Similarly, patients and/or their loved ones can use this application to search for clinical trials. A video demo and screenshots of the new application are available at TrialX Mobile (http://trialx.com/mobile).

Since its inception in May 2008, TrialX has been committed to innovatively putting technology in the hands of health consumers, this time doing it literally. In 2008, TrialX launched a Personal Health Record based clinical trial matching service integrated with Microsoft HealthVault and Google Health. Soon after, it launched a cool application providing trial search using Twitter (http://blog.trialx.com/2009/03/now-you-can-talk-to-twitt …). In April 2009, TrialX won the prestigious 2009 New York City Entrepreneur Week Business Plan Competition, a weeklong event that brings together promising startups in the city (http://www.nycentweek.com/blog/2009/4/27/congratulations-to-the-winner-of-nycent.html).

TrialX (http://TrialX.com) is a web-based platform that helps patients find and learn about clinical trials that match their health conditions and connect with investigators effortlessly. Our mission is to help save lives by enabling patients to find new treatments in an easy and timely manner. TrialX is developed by Applied Informatics Inc., a New York based Healthcare Information Technology (HIT) company.

Category: News

Leave a Reply